BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19478391)

  • 21. Expression of estrogen receptor beta in human colorectal cancer.
    Xie LQ; Yu JP; Luo HS
    World J Gastroenterol; 2004 Jan; 10(2):214-7. PubMed ID: 14716825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor β expression and colorectal cancer: a systematic review and meta-analysis.
    Niv Y
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1438-42. PubMed ID: 26367493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression.
    Cavallini A; Notarnicola M; Giannini R; Montemurro S; Lorusso D; Visconti A; Minervini F; Caruso MG
    Eur J Cancer; 2005 Jul; 41(10):1487-94. PubMed ID: 15949936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
    Popov VM; Zhou J; Shirley LA; Quong J; Yeow WS; Wright JA; Wu K; Rui H; Vadlamudi RK; Jiang J; Kumar R; Wang C; Pestell RG
    Cancer Res; 2009 Jul; 69(14):5752-60. PubMed ID: 19605405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.
    Balasenthil S; Vadlamudi RK
    J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological significance of the expression of estrogen receptor-beta and vascular endothelial growth factor-A in colorectal cancer.
    Taggarshe D; Lobocki C; Silberberg B; McKendrick A; Mittal VK
    Am Surg; 2012 Dec; 78(12):1376-82. PubMed ID: 23265127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
    León J; Casado J; Carazo A; Sanjuán L; Maté A; Muñoz de Rueda P; de la Cueva P; Quiles R; Ruíz S; Ruíz-Extremera A; Salmerón J
    Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity.
    Nair SS; Nair BC; Cortez V; Chakravarty D; Metzger E; Schüle R; Brann DW; Tekmal RR; Vadlamudi RK
    EMBO Rep; 2010 Jun; 11(6):438-44. PubMed ID: 20448663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
    Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
    J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.
    Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK
    Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas.
    Bates GJ; Fox SB; Han C; Launchbury R; Leek RD; Harris AL; Banham AH
    Breast Cancer Res Treat; 2008 Oct; 111(3):453-9. PubMed ID: 18026833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
    Bernardo C; Monteiro FL; Direito I; Amado F; Afreixo V; Santos LL; Helguero LA
    Front Endocrinol (Lausanne); 2021; 12():684140. PubMed ID: 34690921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling.
    Hasson RM; Briggs A; Carothers AM; Davids JS; Wang J; Javid SH; Cho NL; Bertagnolli MM
    Carcinogenesis; 2014 Jan; 35(1):96-102. PubMed ID: 24104551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
    Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
    IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis.
    Barone M; Scavo MP; Papagni S; Piscitelli D; Guido R; Di Lena M; Comelli MC; Di Leo A
    Scand J Gastroenterol; 2010 Nov; 45(11):1320-8. PubMed ID: 20446826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
    Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
    Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.